Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine

On March 16, 2020, Ukraine's Ministry of Health issued nonspecific interim guidance to continue enrolling patients in opioid agonist therapies (OAT) and transition existing patients to take-home dosing to reduce community COVID-19 transmission. Though the number of OAT patients increased modest...

Descripción completa

Detalles Bibliográficos
Autores principales: Meteliuk, Anna, Galvez de Leon, Samy J., Madden, Lynn M., Pykalo, Iryna, Fomenko, Tatiana, Filippovych, Myroslava, Farnum, Scott O., Dvoryak, Sergii, Islam, Zahedul M., Altice, Frederick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769928/
https://www.ncbi.nlm.nih.gov/pubmed/33191004
http://dx.doi.org/10.1016/j.jsat.2020.108164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769928/
https://www.ncbi.nlm.nih.gov/pubmed/33191004
http://dx.doi.org/10.1016/j.jsat.2020.108164

Ejemplares similares